Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis

ConclusionsLow-dose IL-2 therapy may have a promising role in the treatment of refractory LN as an alternative and safe therapeutic approach. It may be used as multi-target combination therapy in clinical practice.

Source: Rheumatology and Therapy - October 7, 2021 Category: Rheumatology Source Type: research